WHO grade 1 (13/16) and non-recurrent (16/20) meningioma were over-represented in the first, the second regrouping higher grades (29/37) and recurrent tumors (14/16), with decreased EP300 (P = 1.13e-04) and increased FOXM1 (P = 6.62e-07) levels, previously reported in recurrent meningiomas, as down- and upregulated, respectively (11). The gene discussed is FOXM1; the disease is meningioma.